Pulmonary hypertension (PH) is a chronic and life-threatening disease characterized by pulmonary vascular remodeling (PVR), which involves the abnormal proliferation of pulmonary artery smooth muscle cells (PASMCs). These cells exhibit metabolic characteristics akin to cancer cells, particularly in their shift towards glycolysis. The Lon protease 1 (LONP1) has been shown to promote glycolytic reprogramming of tumor cells, conferring a malignant proliferative phenotype. However, the precise role of LONP1 in PH remains unclear. In the present study, Su5416/hypoxia-induced and monocrotaline (MCT)-induced PH rodent models and platelet-derived growth factor BB (PDGF-BB)-induced PASMCs were used to investigate the role and mechanism of LONP1 in PH. The results revealed an upregulation of LONP1 expression in lung tissues from two PH rodent models, as well as in PDGF-BB-induced PASMCs. In vivo knockdown of LONP1 significantly alleviated PASMC mitochondrial dysfunction, reduced glycolytic enzyme expression, and decreased lactate accumulation, thereby mitigating PVR. Additionally, in vitro experiments demonstrated that knockdown or inhibition of LONP1 attenuated glycolytic reprogramming, proliferation, and migration of PASMCs, whereas overexpression of LONP1 had converse effects. Mechanistic studies confirmed that mitochondrial pyruvate carrier 1 (MPC1) was a direct substrate for LONP1-mediated degradation. Functional experiments with MPC1 knockdown and overexpression further elucidated its role in the proliferation and migration of PASMCs. Rescue experiments indicated that MPC1 knockdown abrogated the suppressive effects of LONP1 knockdown on glycolytic reprogramming, proliferation, and migration in PASMCs. Therapeutically, knockdown or pharmacological inhibition of LONP1 significantly reversed MCT-induced PH in rats. Thus, targeting LONP1 may represent a promising therapeutic strategy for PH.
Skip Nav Destination
Article navigation
Research Article|
May 07 2025
LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by degrading MPC1 in pulmonary hypertension Open Access
Mingkang Li;
Mingkang Li
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
12579 School of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, China
Search for other works by this author on:
Wenkang Zhang;
Wenkang Zhang
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
12579 School of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, China
Search for other works by this author on:
Minhao Zhang;
Minhao Zhang
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
12579 School of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, China
Search for other works by this author on:
Linqing Li;
Linqing Li
12579 School of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, China
Search for other works by this author on:
Yuyu Yao;
Yuyu Yao
12579 School of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, ChinaSchool of Medicine, Southeast University, Nanjing, Jiangsu, China
Search for other works by this author on:
Yuhan Qin;
Yuhan Qin
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
Search for other works by this author on:
Dong Wang;
Dong Wang
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
Search for other works by this author on:
Gaoliang Yan;
Gaoliang Yan
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
Search for other works by this author on:
Yong Qiao;
Yong Qiao
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
Search for other works by this author on:
Chengchun Tang
Chengchun Tang
*
718779 Southeast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, ChinaSoutheast University Zhongda Hospital Department of Cardiology, Nanjing, Jiangsu, China
*Correspondence: Chengchun Tang ([email protected])
Search for other works by this author on:
Publisher: Portland Press Ltd
Received:
February 20 2025
Accepted:
May 07 2025
Online ISSN: 1470-8736
Print ISSN: 0143-5221
Funding
Funding Group:
- Award Group:
- Funder(s): National Natural Science Foundation of China
- Award Id(s): NO.82170433
- Funder(s):
- Award Group:
- Funder(s): Jiangsu Provincial Medical Key Discipline (Laboratory)
- Award Id(s): ZDXK202207
- Funder(s):
© 2025 The Author(s).
2025
This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0
Clin Sci (Lond) (2025) CS20255922.
Article history
Received:
February 20 2025
Accepted:
May 07 2025
Citation
Mingkang Li, Wenkang Zhang, Minhao Zhang, Linqing Li, Yuyu Yao, Yuhan Qin, Dong Wang, Gaoliang Yan, Yong Qiao, Chengchun Tang; LONP1 facilitates pulmonary artery smooth muscle cell glycolytic reprogramming by degrading MPC1 in pulmonary hypertension. Clin Sci (Lond) 2025; CS20255922. doi: https://doi.org/10.1042/CS20255922
Download citation file:
128
Views
Cited By
Open Access for all
We offer compliant routes for all authors from 2025. With library support, there will be no author nor reader charges in 5 journals. Check here |
![]() |